Octadecanamide market projected to reach USD 624.0 million by 2035, driven by various industries

From GlobeNewswire: 2025-03-12 06:00:00

The global Octadecanamide Market was valued at USD 350.0 million in 2024, with a projected CAGR of 5.4% to reach USD 624.0 million by 2035. Industries are increasingly using octadecanamide in cosmetics, lubricants, and plastics for performance enhancement and sustainability. The United States leads in promoting non-toxic ingredients in personal care products.

Octadecanamide’s application extends to automotive and industrial sectors, providing friction reduction and processing aid. The market is expected to grow at a 4% CAGR, reaching USD 624.0 million by 2035. North America holds a 35% market share, with an absolute $ opportunity of USD 89.8 million in 2035.

Leading players in the Octadecanamide Market include Adeka Corporation, Emery Oleochemicals, and Kao Corporation. Recent industry developments focus on sustainability and innovation, with companies investing in R&D to enhance product ranges and applications. Collaborations between manufacturers and research institutions drive production advancements for diverse industries.

In June 2024, PMC Biogenix announced an expansion of its Armoslip facility in South Korea, increasing production capacity by 50%. This expansion aims to meet the growing demand for Octadecanamide. Stakeholders prioritizing eco-friendly practices and high-performance solutions can secure a larger market share while contributing to sustainability goals.

Fact.MR offers comprehensive insights into the Octadecanamide Market, covering historical data from 2020 to 2024 and forecasts up to 2035. Market analysis includes different grades, forms, functions, and regions worldwide. For more market studies, Fact.MR also delves into the UV cured hardcoats, ceiling plates, industrial-grade octadecanamide, grease barrier, and gas diffusion layer carbon paper markets.

With a commitment to accurate and reliable market intelligence, Fact.MR empowers businesses with essential data and strategic recommendations. The company’s global presence and experienced analysts ensure clients receive actionable insights to capitalize on emerging opportunities and stay competitive in dynamic markets. Contact Fact.MR for in-depth market research and analysis.



Read more at GlobeNewswire: Octadecanamide Market is Projected to Reach USD 624.0